MAPK superfamily plays an important role in daunomycin-induced apoptosis of cardiac myocytes

Circulation

Volumn 100, Issue 20, 1999, Pages 2100-2107

  Zhu, Weidong ^b   Zou, Yunzeng ^b   Aikawa, Ryuichi ^b   Harada, Koichiro ^b   Kudoh, Sumiyo ^b   Uozumi, Hiroki ^b   Hayashi, Doubun ^b   Gu, Yaping ^b   Yamazaki, Tsutomu ^b   Nagai, Ryozo ^b   Yazaki, Yoshio ^b   Komuro, Issei ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b NONE

Author keywords

Apoptosis; Daunomycin; Kinase; Myocytes

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; CHELATING AGENT; DAUNORUBICIN; DNA FRAGMENT; DOXORUBICIN; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN KINASE; REACTIVE OXYGEN METABOLITE;

AGAR GEL ELECTROPHORESIS; ANIMAL CELL; APOPTOSIS; ARTICLE; CARDIOTOXICITY; CONTROLLED STUDY; DOSE RESPONSE; ENZYME ACTIVITY; HEART MUSCLE CELL; NEWBORN; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0032737882     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.100.20.2100     Document Type: Article

References (31)

1. Mettler FP, Young DM, Ward JM. Adriamycin-induced cardiotoxicity (cardiomyopathy and congestive heart failure) in rats. Cancer Res. 1977; 37:2705-2713.
2. Ferrans VJ. Overview of cardiac pathology in relation to anthracycline cardiotoxicity. Cancer Treat Rep. 1978;62:955-961.
3. 2 block induced by DNA crosslinking agents and its possible consequences. Biochem Pharmacol. 1988;37:2303-2309.
4. Novelli F, Allione A, Bernabei P, Rigamonti L, Forni G. Antiblastic chemotherapy drugs up-modulate interferon-gamma receptor expression on human malignant T cells. Cancer Detect Prev. 1997;21:191-195.
5. Myers CE, McGuire WP, Liss RH, Ifrim I, Grotzinger K, Young RC. Adriamycin: the role of lipid peroxidation in cardiac toxicity and tumor response. Science. 1977;197:165-167.
6. Doroshow JH, Locker GY, Ifrim I, Myers CE. Prevention of doxorubicin cardiac toxicity in the mouse by N-acetylcysteine. J Clin Invest. 1981;68: 1053-1064.
7. Thornalley PJ, Dodd NJ. Free radical production from normal and adriamycin-treated ral cardiac sarcosomes. Biochem Pharmacol. 1985;34:669-674.
8. Davis RJ. MAPKs: new JNK expands the group. Trends Biochem Sci. 1994;19:470-473.
9. Davis RJ. The mitogen-activated protein kinase signal transduction pathway. J Biol Chem. 1993;268:14553-14556.
10. Kyriakis JM, Banerjee P, Nikolakaki E, Dai T, Rubie EA, Ahmad MF, Avruch J, Woodgett JR. The stress-activated protein kinase subfamily of c-Jun kinases. Nature. 1994;369:156-160.
11. Han J, Lee J-D, Ribbs L. Ulevitch RJ. A MAP kinase targeted by endotoxin and hyperosmolarity in mammalian cells. Science. 1994;265:808-811.
12. Satoh T, Nakafuku M, Kaziro Y. Function of Ras as a molecular switch in signal transduction. J Biol Chem. 1992;267:24149-24152.
13. Rozakis AM, McGlade J, Mbamalu G, Pelicci G, Daly R. Li W, Batzer A, Thomas S, Brugge J, Pelicci PG. Association of the Shc and Grb2/Sem5 SH2-containing proteins is implicated in activation of the Ras pathway by tyrosine kinases. Nature. 1992;360:689-692.
14. 1- and α-adrenoceptors. Circulation. 1997;95:1260-1268.
15. Derijard B, Hibi M, Wu IH, Barren T, Su B, Deng T, Karin M, Davis RJ. JNK1: a protein kinase stimulated by UV light and Ha-Ras that binds and phosphorylates the c-Jun activation domain. Cell. 1994;76:1025-1037.
16. Xia Z, Dickens M, Raingeaud J, Davis RJ, Greenberg ME. Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science. 1995;270: 1326-1331.
17. Zhang S, Han J, Sells MA, Chernoff J. Knaus UG, Ulevitch RJ, Bokoch GM. Rho family GTPases regulate p38 mitogen-activated protein kinase through the downstream mediator Pak1. J Biol Chem. 1995;270:23934-23936.
18. Minden A, Lin A, Claret FX, Abo A, Karin M, Selective activation of the JNK signaling cascade and c-Jun transcriptional activity by the small GTPases Rac and Cdc42Hs. Cell. 1995;81:1147-1157.
19. Coso OA, Chiariello M, Yu JC, Teramoto H, Crespo P, Xu N, Miki T, Gutkind JS. The small GTP-binding proteins Rac1 and Cdc42 regulate the activity of the JNK/SAPK signaling pathway. Cell. 1995;81:1137-1146.
20. Strutt DI, Weber U, Mlodzik M. The role of RhoA in tissue polarity and frizzled signalling. Nature. 1997;387:292-295.
21. 2-terminal kinase in cultured cardiac myocytes of neonatal rats. Circ Res. 1997;80:139-146.
22. Aikawa R, Komuro I, Yamazaki T, Zou Y, Kudoh S, Yazaki Y. Oxidative stress activates extracellular signal-regulated kinases through Src and Ras in cultured cardiac myocytes of neonatal rats. J Clin Invest. 1997;100: 1813-1821.
23. Wang XZ, Ron D. Stress-induced phosphorylation and activation of the transcription factor CHOP (GADD153) by p38 MAP Kinase. Science. 1996; 272:1347-1349.
24. Haunstetter A, Izumo S. Apoptosis: basic mechanisms and implications for cardiovascular disease. Circ Res. 1998;82:1111-1129.
25. Greene RF, Collins JM, Jenkins JF, Speyer JL, Myers CE. Plasma pharmacokinetics of adriamycin and adriamycinol: implications for the design of in vitro experiments and treatment protocols. Cancer Res. 1983;43:3417-3421.
26. Ito H, Miller SC, Billingham ME, Akimoto H, Torti SV, Wade R, Gahlmann R, Lyons G, Kedes L, Torti FM. Doxorubicin selectively inhibits muscle gene expression in cardiac muscle cells in vivo and in vitro. Proc Natl Acad Sci USA. 1990;87:4275-4279.
27. Sawyer D, Fukazawa R, Arstall M, Kelly R. Daunorubicin-induced apoptosis in rat cardiac myocytes is inhibited by dexrazoxane. Circ Res. 1999;84: 257-265.
28. Doroshow JH, Locker GY, Myers CE. Enzymatic defenses of the mouse heart against reactive oxygen metabolites: alterations produced by doxorubicin. J Clin Invest. 1980;65:128-135.
29. Lee V, Randhawa AK, Singal PK. Adriamycin-induced myocardial dysfunction in vitro is mediated by free radicals. Am J Physiol. 1991;261: H989-H995.
30. Whisler RL, Goyette MA, Grants IS, Newhouse YG. Sublethal levels of oxidant stress stimulate multiple serine/threonine kinases and suppress protein phosphatases in Jurkat T cells. Arch Biochem Biophys. 1995;319:23-35.
31. 2-terminal kinases, in human epithelial cells, by 2 independent pathways. Biochem Biophys Res Commun. 1998;251:166-172.